comparemela.com
Latest Breaking News On - Company or we our - Page 2 : comparemela.com
Sapu BioScience and Cromos Pharma initiating P201 – A
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced.
Sapu
Xizang
China
Poland
Croatia
Kazakhstan
Romania
Lithuania
Moldova
Estonia
Slovenia
Ukraine
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer
AGOURA HILLS, Calif., Aug. 23, 2023 Oncotelic Therapeutics, Inc , announced today its joint venture partner, GMP Biotechnology Limited’s wholly owned subsidiary – Sapu Bioscience, LLC ,.
Sapu
Xizang
China
Latvia
Serbia
Bulgaria
Hungary
Georgia
United-states
Poland
Croatia
Kazakhstan
vimarsana © 2020. All Rights Reserved.